Supply of buprenorphine waivered physicians: the influence of state policies
- PMID: 25218919
- PMCID: PMC4420477
- DOI: 10.1016/j.jsat.2014.07.010
Supply of buprenorphine waivered physicians: the influence of state policies
Abstract
Buprenorphine, an effective opioid use disorder treatment, can be prescribed only by buprenorphine-waivered physicians. We calculated the number of buprenorphine-waivered physicians/100,000 county residents using 2008-11 Buprenorphine Waiver Notification System data, and used multivariate regression models to predict number of buprenorphine-waivered physicians/100,000 residents in a county as a function of county characteristics, state policies and efforts to promote buprenorphine use. In 2011, 43% of US counties had no buprenorphine-waivered physicians and 7% had 20 or more waivered physicians. Medicaid funding, opioid overdose deaths, and specific state guidance for office-based buprenorphine use were associated with more buprenorphine-waivered physicians, while encouraging methadone programs to promote buprenorphine use had no impact. Our findings provide important empirical information to individuals seeking to identify effective approaches to increase the number of physicians able to prescribe buprenorphine.
Keywords: Buprenorphine; Medicaid; Medication assisted treatment; Opioid use disorder; State policy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.Milbank Q. 2015 Sep;93(3):561-83. doi: 10.1111/1468-0009.12137. Milbank Q. 2015. PMID: 26350930 Free PMC article.
-
The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.Health Serv Res. 2020 Jun;55(3):383-392. doi: 10.1111/1475-6773.13282. Epub 2020 Mar 12. Health Serv Res. 2020. PMID: 32166761 Free PMC article.
-
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943. JAMA Netw Open. 2018. PMID: 30646185 Free PMC article.
-
Medications for management of opioid use disorder.Am J Health Syst Pharm. 2019 Jul 18;76(15):1097-1103. doi: 10.1093/ajhp/zxz105. Am J Health Syst Pharm. 2019. PMID: 31361869 Review.
-
Buprenorphine initiation to treat opioid use disorder in emergency rooms.J Neurol Sci. 2020 Apr 15;411:116716. doi: 10.1016/j.jns.2020.116716. Epub 2020 Feb 6. J Neurol Sci. 2020. PMID: 32097813 Review.
Cited by
-
The state of the science in opioid policy research.Drug Alcohol Depend. 2020 Sep 1;214:108137. doi: 10.1016/j.drugalcdep.2020.108137. Epub 2020 Jun 27. Drug Alcohol Depend. 2020. PMID: 32652376 Free PMC article. Review.
-
Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records.Transl Psychiatry. 2024 Jan 10;14(1):20. doi: 10.1038/s41398-023-02713-x. Transl Psychiatry. 2024. PMID: 38200003 Free PMC article.
-
Navigating addiction treatment during COVID-19: policy insights from state health leaders.Health Aff Sch. 2024 Jan 29;2(2):qxae007. doi: 10.1093/haschl/qxae007. eCollection 2024 Feb. Health Aff Sch. 2024. PMID: 38344412 Free PMC article.
-
To Prescribe or Not to Prescribe?: Barriers and Motivators for Progressing Along Each Stage of the Buprenorphine Training and Prescribing Path.J Behav Health Serv Res. 2023 Apr;50(2):165-180. doi: 10.1007/s11414-021-09783-z. Epub 2022 Jan 21. J Behav Health Serv Res. 2023. PMID: 35060002
-
Buprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment Organizations.J Addict Behav Ther Rehabil. 2015;4(2):1000140. doi: 10.4172/2324-9005.1000140. J Addict Behav Ther Rehabil. 2015. PMID: 26380328 Free PMC article.
References
-
- American Methadone Treatment Association. Methadone maintenance program and patient census in the US. New York: American Methadone Treatment Association; 1998.
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, D.C: American Psychiatric Press, Inc; 1994. (DSM-IV)
-
- American Psychiatric Association. DSM V. American Psychiatric Association; 2013.
-
- Arfken CL, Johanson CE, di Menza S, Schuster CR. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians. Journal of Substance Abuse Treatment. 2010;39(2):96–104. - PubMed
-
- Ball J, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. New York: Springer-Verlag; 1991.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical